Short-Term Therapy with Oral Olpadronate in Active Paget's Disease of Bone-Reference-Cited by-同舟云学术

Short-Term Therapy with Oral Olpadronate in Active Paget's Disease of Bone

Published:1999-12-01 Issue:12 Volume:14 Page:2042-2047
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

González Diana C.,Mautalen Carlos A.

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Clinical Review: Paget's disease of bone;Siris;J Bone Miner Res,1998

2. Paget's disease of bone: Clinical, pathogenetic and therapeutic aspects;Papapoulos;Bailliere's Clin Endocrinol Metab,1997

3. Enhancement of the inhibitory action of APD on the transformation of osteoclasts precursors into resorting cells after dimethylation of the amino group;Boonekamp;Bone Miner,1987

4. Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile;Vega;Drugs Exp Clin Res,1994

5. Tratamiento de la enfermedad de Paget con olpadronato: Su eficacia terapéutica en respondedores parciales al pamidronato oral;González;Medicina (Buenos Aires),1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Italian guidelines for the diagnosis and treatment of Paget’s disease of bone;Reumatismo;2011-09-12

2. Tratamiento de la enfermedad de Paget;Reumatología Clínica;2007-03

3. Endothelin-1 Levels in Patients with Paget's Disease of Bone;Experimental and Clinical Endocrinology & Diabetes;2005-11-30

4. Determinants of induction and duration of remission of Paget's disease of bone after bisphosphonate (olpadronate) therapy;Bone;2003-11

5. Relationships Between Pharmacokinetics and Rate of Bone Turnover After Intravenous Bisphosphonate (Olpadronate) in Patients With Paget's Disease of Bone;Journal of Bone and Mineral Research;2003-05-01